Masunari Fushimi

Title: Masunari Fushimi: Innovator in Sustained-Release Drug Formulation

Introduction

Masunari Fushimi is a notable inventor based in Narashino, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug formulations that enhance therapeutic efficacy while minimizing side effects.

Latest Patents

Fushimi holds a patent for a sustained-release pranoprofen preparation. This innovative formulation comprises an effective amount of pranoprofen along with one or more sustained-release components, which can include oily, water-soluble, water-insoluble, and intestinally soluble components. The preparation is designed to control the release of pranoprofen, lowering the maximum concentration of the drug in the blood while maintaining its levels over an extended period. This approach reduces the risks of side effects and allows for effective treatment with dosing only once or twice a day.

Career Highlights

Throughout his career, Fushimi has worked with prominent companies in the pharmaceutical industry, including Ss Pharmaceutical Co., Ltd. and Dojin Iyaku Kako Co., Ltd. His work has focused on improving drug delivery systems and enhancing patient outcomes through innovative formulations.

Collaborations

Fushimi has collaborated with notable colleagues such as Hideyoshi Kanbe and Yoichi Sawayanagi. These partnerships have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Masunari Fushimi's contributions to sustained-release drug formulations exemplify the impact of innovation in the pharmaceutical industry. His work not only enhances the effectiveness of treatments but also prioritizes patient safety and convenience.